Knowledge of motivations for and barriers to trial participation as well as the acceptability of investigations, time commitments and routes of drug administration should inform better, more patient focused trial design. This in turn may improve recruitment and retention of participants to future trials.
Monday, January 17, 2022
The attitude of patients with progressive ataxias towards clinical trials
Gilbert Thomas-Black, Andrada Dumitrascu, Hector Garcia-Moreno, Julie Vallortigara, Julie Greenfield, Barry Hunt, Susan Walther, Mackenzie Wells, David R. Lynch, Hugh Montgomery & Paola Giunti. Orphanet J Rare Dis 17, 1 (2022). doi:10.1186/s13023-021-02091-x
